Federico Nichetti

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data

Margherita Rimini, Lorenzo Fornaro, Sara Lonardi et al. · Liver International · 2023 · 117 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients

Federico Nichetti, Francesca Ligorio, Emma Zattarin et al. · Cancers · 2019 · 67 citations · Full text

Medicine, Oncology, Pharmacology +15

Trifluridine/Tipiracil (TAS-102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program

Chiara Cremolini, Daniele Rossini, Erika Martinelli et al. · The Oncologist · 2018 · 58 citations · Full text

Medicine, Oncology, Pharmacology +16

Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program

Arsela Prelaj, Achille Bottiglieri, Claudia Proto et al. · European Journal of Cancer · 2021 · 58 citations

Medicine, Genetics, Molecular Genetics +16

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population

Margherita Rimini, Lorenzo Fornaro, Mario Domenico Rizzato et al. · European Journal of Cancer · 2024 · 44 citations · Full text

Medicine, Oncology, Pharmacology +13